# Cabinet approves NT$5 billion toward a new-cancer-drug fund under Healthy Taiwan

Date: 2024

## The fact

On 11 July 2024 the Executive Yuan approved a Ministry of Health and Welfare proposal to fund new cancer medicines, allocating NT$5 billion from the next year’s budget toward a temporary new-cancer-drug fund intended to grow to NT$10 billion, as part of Lai’s Healthy Taiwan aim to cut age-standardised cancer mortality by one-third by 2030. NHI remains a shared bureau.

## Context

NHI’s thirtieth year sat as parent. Neighbouring Healthy Taiwan committee in November is a child restatement. He is a physician-president, not every oncologist.

28 November 2024 Healthy Taiwan committee is a child. 20 May oath is the parent presidency.

The president of the Republic of China (Taiwan) is head of state under the Additional Articles and commander-in-chief. He does not write a PLA communique, a TSMC capex print, or a Legislative Yuan majority. A National Day address is not a completed interceptor. An inaugural line is not a PLA missile. A special-act press conference is not a passed statute. [William Lai](/people/lai-ching-te) is a common English name for the same person; the stored English name is Lai Ching-te.

## Evidence and sources

Executive Yuan ROC (Taiwan) carries the official instrument or communique. Taipei Times records the same dated act independently.

## Significance

The path is health-system capacity: a completed named cancer-drug fund under NHI.

## What is established and what is not

Established: 11 July 2024 cabinet approval, independently reported; NT$5 billion named.

Not established: that every cancer death was thereby avoided that Thursday, or a unique later mortality coefficient from day one.

What would change the picture: a contradictory original with a different date or name, a later repeal, a court that vacated the instrument, or a measured series that can be argued, with lag and alternatives, as a consequence of this instrument rather than of later institutions.

The date is the date of this instrument, not a licence to back-date every later harm or benefit.

The cabinet approved. NHIA pays. He owned Healthy Taiwan as brand.. A later repeal, court stay, or successor order would be a different Fact with a different date. That pair identifies Cabinet approves NT$5 billion toward a new-cancer-drug fund under Healthy Taiwan, not a later speech about Cabinet approves NT$5 billion toward a new-cancer-drug fund under Healthy Taiwan.

Co-authors and later implementers named in Context remain on the file. Cabinet approves NT$5 billion toward a new-cancer-drug fund under Healthy Taiwan on 2024-07-11 is not a licence to treat every later Executive Yuan ROC (Taiwan) communique as this same act. If a later repeal, stay, or successor instrument exists, it needs its own date and its own row. This dossier refuses to average Cabinet approves NT$5 billion toward a new-cancer-drug fund under Healthy Taiwan into a personality. The contribution described on this Person row is limited to MOHW proposed. The cabinet approved. NHIA pays. He owned Healthy Taiwan as brand. That limit is the alternative to treating office-holding as authorship of every later series.

## People

- Lai Ching-te: https://factrail.ai/people/lai-ching-te

## Drivers

- Health-System Capacity: https://factrail.ai/drivers/health-system-capacity
- Household Purchasing Power: https://factrail.ai/drivers/household-purchasing-power

## Sources

- https://www.taipeitimes.com/News/front/archives/2024/07/12/2003820687
- https://english.ey.gov.tw/

## Methodology

https://factrail.ai/methodology

Canonical: https://factrail.ai/facts/tw-lai-cancer-2024
